Icon (ICLR) Competitors $195.01 +27.12 (+16.15%) Closing price 04:00 PM EasternExtended Trading$193.32 -1.69 (-0.87%) As of 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICLR vs. MEDP, CRL, IQV, TMO, TCOM, RDDT, CPAY, TOST, GIB, and GRABShould you be buying Icon stock or one of its competitors? The main competitors of Icon include Medpace (MEDP), Charles River Laboratories International (CRL), IQVIA (IQV), Thermo Fisher Scientific (TMO), Trip.com Group (TCOM), Reddit (RDDT), Corpay (CPAY), Toast (TOST), CGI Group (GIB), and Grab (GRAB). Icon vs. Its Competitors Medpace Charles River Laboratories International IQVIA Thermo Fisher Scientific Trip.com Group Reddit Corpay Toast CGI Group Grab Medpace (NASDAQ:MEDP) and Icon (NASDAQ:ICLR) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends. Do analysts rate MEDP or ICLR? Medpace currently has a consensus target price of $395.60, indicating a potential downside of 13.18%. Icon has a consensus target price of $203.42, indicating a potential upside of 4.31%. Given Icon's stronger consensus rating and higher possible upside, analysts plainly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 2 Sell rating(s) 10 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00Icon 0 Sell rating(s) 6 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.67 Do institutionals and insiders have more ownership in MEDP or ICLR? 78.0% of Medpace shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 20.3% of Medpace shares are owned by insiders. Comparatively, 44.0% of Icon shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, MEDP or ICLR? Medpace has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500. Which has stronger valuation and earnings, MEDP or ICLR? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.11B6.21$404.39M$13.1034.78Icon$8.28B1.90$791.47M$9.1821.24 Is MEDP or ICLR more profitable? Medpace has a net margin of 18.74% compared to Icon's net margin of 9.25%. Medpace's return on equity of 67.66% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Medpace18.74% 67.66% 21.86% Icon 9.25%11.46%6.49% Does the media refer more to MEDP or ICLR? In the previous week, Medpace had 23 more articles in the media than Icon. MarketBeat recorded 36 mentions for Medpace and 13 mentions for Icon. Medpace's average media sentiment score of 0.77 beat Icon's score of 0.07 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 10 Very Positive mention(s) 8 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Icon 3 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMedpace beats Icon on 9 of the 17 factors compared between the two stocks. Get Icon News Delivered to You Automatically Sign up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICLR vs. The Competition Export to ExcelMetricIconMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.75B$7.22B$5.67B$9.49BDividend YieldN/A2.80%4.05%4.00%P/E Ratio21.2425.2327.9419.95Price / Sales1.9040.87396.5882.68Price / Cash8.0627.1236.1958.45Price / Book1.659.728.635.82Net Income$791.47M$239.98M$3.24B$258.42M7 Day Performance32.77%1.50%3.22%1.94%1 Month Performance31.28%5.63%10.72%12.02%1 Year Performance-41.22%17.99%34.94%20.80% Icon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICLRIcon3.3557 of 5 stars$195.01+16.2%$203.42+4.3%-49.5%$15.75B$8.28B21.2441,900Trending NewsEarnings ReportAnalyst UpgradeGap UpHigh Trading VolumeMEDPMedpace3.9665 of 5 stars$308.88-1.0%$344.82+11.6%+22.4%$8.96B$2.11B23.815,900Trending NewsEarnings ReportAnalyst ForecastHigh Trading VolumeCRLCharles River Laboratories International4.449 of 5 stars$149.70-3.1%$174.54+16.6%-23.8%$7.59B$4.05B-230.3120,100Positive NewsGap UpIQVIQVIA4.5262 of 5 stars$159.06-1.0%$222.45+39.9%-18.6%$27.79B$15.41B15.5688,000Trending NewsEarnings ReportAnalyst ForecastTMOThermo Fisher Scientific4.9614 of 5 stars$405.15-2.3%$599.30+47.9%-15.5%$156.57B$42.88B18.94125,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionTCOMTrip.com Group4.5019 of 5 stars$63.37-0.4%$77.25+21.9%+39.5%$41.55B$7.30B19.4541,073Positive NewsRDDTReddit2.618 of 5 stars$146.22-1.4%$142.46-2.6%+115.5%$27.35B$1.30B251.252,233Trending NewsUpcoming EarningsAnalyst ForecastInsider TradeAnalyst RevisionCPAYCorpay3.3182 of 5 stars$331.16-0.3%$401.07+21.1%+18.8%$23.41B$3.97B18.1811,200News CoveragePositive NewsTOSTToast2.7745 of 5 stars$47.39+1.9%$43.17-8.9%+75.4%$23.17B$4.96B193.835,700GIBCGI Group4.1356 of 5 stars$100.35+0.8%$156.75+56.2%-4.9%$22.33B$10.79B17.4690,250News CoveragePositive NewsUpcoming EarningsGRABGrab1.0427 of 5 stars$5.35+0.2%$5.82+8.7%+58.9%$21.50B$2.80B267.0011,267 Related Companies and Tools Related Companies MEDP Alternatives CRL Alternatives IQV Alternatives TMO Alternatives TCOM Alternatives RDDT Alternatives CPAY Alternatives TOST Alternatives GIB Alternatives GRAB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICLR) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icon Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Icon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
